207 related articles for article (PubMed ID: 14743372)
1. Genetic markers and the majority's right not to know.
Appel J; Friedman JH
Mov Disord; 2004 Jan; 19(1):113-4. PubMed ID: 14743372
[No Abstract] [Full Text] [Related]
2. Ethical considerations of genetic testing.
Fleming DA
J Clin Ethics; 2002; 13(4):316-23. PubMed ID: 12793324
[No Abstract] [Full Text] [Related]
3. Presumed rapid eye movement behavior disorder in Machado-Joseph disease (spinocerebellar ataxia type 3).
Friedman JH
Mov Disord; 2002 Nov; 17(6):1350-3. PubMed ID: 12465081
[TBL] [Abstract][Full Text] [Related]
4. Ethics, genetics and science policy.
Tranoy KE
Bull Med Ethics; 1992 Apr; (77):13-20. PubMed ID: 15997530
[TBL] [Abstract][Full Text] [Related]
5. Non-movement disorder heralds symptoms of Machado-Joseph disease years before ataxia.
D'Abreu A; Friedman J; Coskun J
Mov Disord; 2005 Jun; 20(6):739-41. PubMed ID: 15747372
[TBL] [Abstract][Full Text] [Related]
6. [DNA microarrays and the right not to know].
Solberg B
Tidsskr Nor Laegeforen; 2001 Apr; 121(10):1274-8. PubMed ID: 11402761
[No Abstract] [Full Text] [Related]
7. Testing for the Huntington gene: a right to know, a right not to know, or a duty to know.
Shaw MW
Am J Med Genet; 1987 Feb; 26(2):243-6. PubMed ID: 2949608
[No Abstract] [Full Text] [Related]
8. Ethical aspects of early diagnosis of genetic diseases.
Berg K
World Health; 1996; 49(5):20-1. PubMed ID: 17333578
[No Abstract] [Full Text] [Related]
9. REM sleep behavior disorder and SCA-3 (Machado-Joseph disease).
Syed BH; Rye DB; Singh G
Neurology; 2003 Jan; 60(1):148. PubMed ID: 12525744
[No Abstract] [Full Text] [Related]
10. [Social and family considerations in genetic counselling].
Svendsen MN; Koch L
Ugeskr Laeger; 2006 Jun; 168(24):2348-50. PubMed ID: 16822418
[TBL] [Abstract][Full Text] [Related]
11. The patient's right to know--a reprise.
Kelly LS
Nurs Outlook; 1983; 31(1):6-9. PubMed ID: 6549834
[No Abstract] [Full Text] [Related]
12. Occupational and environmental health in the 21st century: the new frontier in genetics and disease prevention.
Rischitelli DG; Berman F; McCauley LA
AAOHN J; 2005 Dec; 53(12):522-8. PubMed ID: 16401059
[TBL] [Abstract][Full Text] [Related]
13. Choosing not to know: accounts of non-engagement with pre-symptomatic testing for Machado-Joseph disease.
Mendes Á; Paneque M; Clarke A; Sequeiros J
Eur J Hum Genet; 2019 Mar; 27(3):353-359. PubMed ID: 30573801
[TBL] [Abstract][Full Text] [Related]
14. The Human Genome Project and public perception: truth and consequences.
Pelias MZ; Markward NJ
Emory Law J; 2000; 49(3):837-58. PubMed ID: 12645564
[No Abstract] [Full Text] [Related]
15. Genetic testing in neuromuscular disease.
Krajewski KM; Shy ME
Neurol Clin; 2004 Aug; 22(3):481-508, v. PubMed ID: 15207873
[TBL] [Abstract][Full Text] [Related]
16. Psychological aspects of pre-symptomatic testing for Machado-Joseph disease and familial amyloid polyneuropathy type I.
Rolim L; Leite A; Lêdo S; Paneque M; Sequeiros J; Fleming M
Clin Genet; 2006 Apr; 69(4):297-305. PubMed ID: 16630162
[TBL] [Abstract][Full Text] [Related]
17. Genetic testing and human subjects in research.
Laidlaw SA; Raffel LJ; Daar JF
Whittier Law Rev; 2002; 24(2):429-72. PubMed ID: 15085855
[No Abstract] [Full Text] [Related]
18. Ethical problems in biological research in medicine.
Serra A
Dolentium Hominum; 1995; 10(1):130-7. PubMed ID: 15839017
[No Abstract] [Full Text] [Related]
19. [Information for family members with an increased risk for a genetic disease].
Gordijn B
Dtsch Med Wochenschr; 2006 Mar; 131(11):573-6. PubMed ID: 16538564
[TBL] [Abstract][Full Text] [Related]
20. Ethical issues in ocular genetics.
Mezer E; Wygnanski-Jaffe T
Curr Opin Ophthalmol; 2009 Sep; 20(5):382-6. PubMed ID: 19587598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
